Dual versus triple antithrombotic therapy, does trial design make the difference?

31 August 2020 (12:11 - 12:22)
Organised by:
Congress Presentation Part of: Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

The Event

Event poster

ESC Congress 2020

31 August 2020 12:11 CET